Loading clinical trials...
Loading clinical trials...
A randomized, international, phase III, multi-center, non- inferiority trial assessing the safety and efficacy of Magtrace® (superparamagnetic iron oxide, SPIO) in identification of lymph nodes in pat...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Vastra Gotaland Region
NCT07287917 · Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer
NCT07410676 · Cancer, Sarcoma, and more
NCT06545682 · Melanoma (Skin Cancer), Breast Cancer, and more
NCT06605443 · Melanoma (Skin Cancer), Nevi and Melanomas, and more
NCT07428941 · Skin Lesions, Melanocytic Nevi, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions